US 8252267
DKKL-1 splice product modulators for cancer diagnosis and therapy
granted A61PA61P35/00
Quick answer
US patent 8252267 (DKKL-1 splice product modulators for cancer diagnosis and therapy) held by Sagres Discovery, Inc. expires Mon Aug 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sagres Discovery, Inc.
- Grant date
- Tue Aug 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61P, A61P35/00